XTL Biopharmaceuticals Ltd.
Patents, Design & Utilities
Last updated:
List of all XTL Biopharmaceuticals Ltd. patents 1 in total
Status | Patent |
---|---|
Application | Utility: PHARMACEUTICAL COMPOSITIONS COMPRISING 0.25 MG DOSE OF SYNTHETIC HUMAN PEPTIDES FOR TREATING SYSTEMIC LUPUS ERYTHEMATOSUS Filling date: 7 Sep 2025 Issue date: 29 Oct 2020 |
Showing 1 to 1 of 1 patents.